Atrial fibrillation (AF) is independently associated with increased risks of mortality, stroke, heart failure, impaired quality of life, and cognitive decline. Rhythm control has proven superior to rate control in reducing cardiovascular outcomes, with catheter ablation demonstrating greater efficacy than antiarrhythmic drug therapy.– Continuous advances in techniques and technologies have progressively established ablation as a cornerstone in the management of AF. In recent years, 3D mapping and point-by-point ablation have evolved significantly with the introduction of contact force-sensing catheters and […]

Atrial fibrillation (AF) is the most common sustained arrhythmia in the population and its incidence significantly increases with age. As life expectancy rises, it is estimated that AF prevalence will suffer a significant increase, and its adequate control will continue to be a major challenge. Until the end of the 90s, the therapeutic options available and most used in the reversion and prevention of AF recurrences were antiarrhythmic drugs (AA) and electrical cardioversion; however, clinical treatment with AA drugs has […]